Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients. [electronic resource]
- Cardiovascular & hematological disorders drug targets 2018
- 234-238 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2212-4063
10.2174/1871529X18666180419101416 doi
Chronic Disease DNA Methylation Drug Resistance, Neoplasm--genetics Humans Imatinib Mesylate--pharmacology Leukemia, Myeloid--drug therapy Promoter Regions, Genetic Suppressor of Cytokine Signaling 1 Protein--genetics